The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to biopharmaceutical company Amarin for its claims related to Vascepa and FDA-approved MARINE indication. The NOA, which is issued based on patent ...
Tags: NOA, Vascepa capsules, biopharmaceutical
Clinical stage biotechnology company Aphios has obtained notification of allowance(NOA)from the US Patent and Trademark Office(USPTO)for its patent application for oral delivery of insulin. The patent entitled'Polymer ...
Tags: Aphios, USPTO, oral delivery of insulin, NOA
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Echo Therapeutics' claimed application for its Prelude SkinPrep system and Symphony tCGM system. The claimed Patent Application No. 10/792,862 entitled ...
Tags: USPTO, NOA, application, notice of allowance, Prelude SkinPrep system
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Sanovas' minimally invasive nested balloon catheter for localized drug delivery. The patent will protect an integral part of the company's NanoVas ...
Tags: USPTO, NOA, minimally invasive nested balloon catheter, medical product
Specialty pharmaceutical company Cynapsus Therapeutics has received a Notice of Allowance from the US Patent and Trademark Office (USPTO) for a patent application No. 13/445,656 that covers APL-130277. Fast-acting APL-130277 is a thin ...
The US Patent and Trademark Office (USPTO) has granted notice of allowance (NOA) to SkyePharma for a patent application 2012/0177734 of RAYOS (Prednisone) delayed-release tablets. The NOA covers the FDA-approved RAYOS, which uses the ...
Tags: SkyePharma, RAYOS delayed-release tablets, rheumatoid arthritis
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Arrowhead Research's new formulation of dynamic polyconjugate (DPC) siRNA delivery system. The patent application No.13/032,029 covers claims for ...
Tags: siRNA delivery system, US Patent, dynamic polyconjugate, DPC platform
The US Patent and Trademark Office(USPTO)has granted a Notice of Allowance(NOA)to Silence Therapeutics for claims related to interfering RNA molecules and lipid complexes used in drug delivery. The NOA,which is issued based on the ...
Tags: Silence Therapeutics, RNAi therapeutics, Silence Company, RNA molecules
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) for Quick-Med Technologies' patent protecting new antimicrobial technology, Stay Fresh. The active antimicrobial agent utilizes non-toxic hydrogen peroxide ...
Tags: antimicrobial technology, Health
Intellect Neurosciences has won a notice of allowance (NOA) from the European Patent Office for its OX1, which has been licensed to ViroPharma for Friedrich's Ataxia and other neurodegenerative diseases. The OX1 patent relates to a new ...
Tags: neurodegenerative disease, patent, notice of allowance